Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  58003-03s1 In Vitro Analysis of Estrogen Induced Tumorigenesis End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
58003-03s1 In Vitro Analysis of Estrogen Induced Tumorigenesis



  1. Sponsor Organization: NIH/NCI

  2. Project Title: 58003-03S1 IN VITRO ANALYSIS OF ESTROGEN INDUCED TUMORIGENESIS

  3. Project Focus: EXPOSURE ASSESSMENT

  4. Description: An estimated 40-6030f human cancers are associated with sex hormone exposure. Examination of the importanceof estrogens as carcinogens or cocarcinogens in the development of cancer requires evaluations of estrogen effectsduring the various stages of estrogen-induced tumor formation. One experimental model for examining the possiblerole(s) of estrogens in tumor development is the Syrian hamster. Castrated juvenile male golden Syrian hamsters andovariectomized female Syrian hamsters will produce kidney tumors after prolonged exposure (9 to 12 months) to thesteroidal estrogen estradiol (E2) or to the nonsteroidal estrogen diethylstilbestrol (DES). This unique in vivo model ofestrogen carcinogenicity may provide important insights into the molecular processes by which estrogens induce cancerdevelopment. Recent research with this animal model in our laboratories has shown that estrogens produce dysplasticfoci within three months of estrogen treatment in hamsters and identified differences in the extent of estrogen metabolismin primary kidney cell cultures and in kidney tissue slices. The focus of our research is the elucidation of the role(s) ofestrogens in biochemical events leading to tumor formation. Our current working hypothesis is that continuous exposureof target cells to estrogens results in hormonally-induced changes in cellular biochemistry. These changes increase thevulnerability of the cells by exposing critical regions of the DNA, by altering metabolism to increase concentrations of potentially reactive compounds, and/or by modifying levels of proteins important for growth and cell division. Genotoxic and nongenotoxic insults at carcinogenic targets in the hormonally-induced cell then result in phenotypicalterations in gene expression. This collaborative, multidisciplinary proposal addresses the hypothesis by developing invitro cell systems with varying tumorigenic potential and analyzing the effects of various estrogens (agonists,metabolites, antagonists) on parameters during stages of tumorigenesis.

  5. References:

  6. Category: MODELS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: LABORATORY STUDY, IN VIVO, IN VITRO

  9. Keywords for Experimental Endpoints: MOLECULAR, GENE EXPRESSION, CARCINOGENESIS, SEX STEROIDS

  10. Chemical Agents: SEX HORMONES, ESTROGEN

  11. Performing Institution: OHIO STATE UNIVERSITY

  12. Contact: CONTACT PERSON:ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301 496-5515; LEEE@0D.NCI.NIH.GOV


 

 
Begin Site Footer